91 related articles for article (PubMed ID: 1495020)
1. Probing the molecular basis of resistance to pyrimethamine by site-directed mutagenesis.
Wagner CR; Benkovic SJ
J Med Chem; 1992 Jul; 35(15):2912-5. PubMed ID: 1495020
[No Abstract] [Full Text] [Related]
2. Dihydrofolate reductase from pyrimethamine-resistant Plasmodium berghei.
Ferone R
J Biol Chem; 1970 Feb; 245(4):850-4. PubMed ID: 5418106
[No Abstract] [Full Text] [Related]
3. Plasmodium berghei dihydrofolate reductase. Isolation, properties, and inhibition by antifolates.
Ferone R; Burchall JJ; Hitchings GH
Mol Pharmacol; 1969 Jan; 5(1):49-59. PubMed ID: 4392112
[No Abstract] [Full Text] [Related]
4. Novel alleles of Plasmodium falciparum dhfr that confer resistance to chlorcycloguanil.
Hunt SY; Rezvani BB; Sibley CH
Mol Biochem Parasitol; 2005 Jan; 139(1):25-32. PubMed ID: 15610816
[TBL] [Abstract][Full Text] [Related]
5. The dihydrofolate reductase domain of rodent malarias: point mutations and pyrimethamine resistance.
Cheng Q; Saul A
Mol Biochem Parasitol; 1994 Jun; 65(2):361-3. PubMed ID: 7969277
[No Abstract] [Full Text] [Related]
6. Addressing cumulative selection.
Behe MJ
Science; 2007 Oct; 318(5848):196; author reply 196. PubMed ID: 17932270
[No Abstract] [Full Text] [Related]
7. [A new cytochemical method for the study of the tetrahydrofolatereductase activity in Plasmodium berghei: analysis of the effect of specific inhibitors].
Gerzeli G; Polver Pde P
Riv Parassitol; 1969 Mar; 30(1):19-26. PubMed ID: 5405877
[No Abstract] [Full Text] [Related]
8. Virulence and drug resistance in malaria parasites.
Stein WD; Sanchez CP; Lanzer M
Trends Parasitol; 2009 Oct; 25(10):441-3. PubMed ID: 19734096
[TBL] [Abstract][Full Text] [Related]
9. Action of pyrimethamine and related drugs against Plasmodium knowlesi in vitr.
Gutteridge WE; Trigg PI
Parasitology; 1971 Jun; 62(3):431-44. PubMed ID: 4997058
[No Abstract] [Full Text] [Related]
10. Molecular dynamics of interactions between rigid and flexible antifolates and dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant Plasmodium falciparum.
Mokmak W; Chunsrivirot S; Hannongbua S; Yuthavong Y; Tongsima S; Kamchonwongpaisan S
Chem Biol Drug Des; 2014 Oct; 84(4):450-61. PubMed ID: 24716467
[TBL] [Abstract][Full Text] [Related]
11. Use of bacterial surrogates as a tool to explore antimalarial drug interaction: Synergism between inhibitors of malarial dihydrofolate reductase and dihydropteroate synthase.
Talawanich Y; Kamchonwongpaisan S; Sirawaraporn W; Yuthavong Y
Acta Trop; 2015 Sep; 149():64-9. PubMed ID: 25997881
[TBL] [Abstract][Full Text] [Related]
12. Kinetic and molecular properties of dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant Plasmodium chabaudi.
Sirawaraporn W; Yuthavong Y
Mol Biochem Parasitol; 1984 Mar; 10(3):355-67. PubMed ID: 6727925
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
Basco LK; Ringwald P
Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484
[TBL] [Abstract][Full Text] [Related]
14. Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi.
Alker AP; Mwapasa V; Purfield A; Rogerson SJ; Molyneux ME; Kamwendo DD; Tadesse E; Chaluluka E; Meshnick SR
Antimicrob Agents Chemother; 2005 Sep; 49(9):3919-21. PubMed ID: 16127071
[TBL] [Abstract][Full Text] [Related]
15. Plasmodium falciparum: direct cloning and expression of pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase domains.
Hekmat-Nejad M; Lee PC; Rathod PK
Exp Parasitol; 1997 Mar; 85(3):303-5. PubMed ID: 9085928
[No Abstract] [Full Text] [Related]
16. Heterologous expression of active thymidylate synthase-dihydrofolate reductase from Plasmodium falciparum.
Sirawaraporn W; Sirawaraporn R; Cowman AF; Yuthavong Y; Santi DV
Biochemistry; 1990 Dec; 29(48):10779-85. PubMed ID: 2176883
[TBL] [Abstract][Full Text] [Related]
17. In vitro generation of novel pyrimethamine resistance mutations in the Toxoplasma gondii dihydrofolate reductase.
Reynolds MG; Oh J; Roos DS
Antimicrob Agents Chemother; 2001 Apr; 45(4):1271-7. PubMed ID: 11257045
[TBL] [Abstract][Full Text] [Related]
18. In silico screening against wild-type and mutant Plasmodium falciparum dihydrofolate reductase.
Fogel GB; Cheung M; Pittman E; Hecht D
J Mol Graph Model; 2008 Apr; 26(7):1145-52. PubMed ID: 18037315
[TBL] [Abstract][Full Text] [Related]
19. Conflicting requirements of Plasmodium falciparum dihydrofolate reductase mutations conferring resistance to pyrimethamine-WR99210 combination.
Japrung D; Leartsakulpanich U; Chusacultanachai S; Yuthavong Y
Antimicrob Agents Chemother; 2007 Dec; 51(12):4356-60. PubMed ID: 17875995
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria.
Peterson DS; Milhous WK; Wellems TE
Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3018-22. PubMed ID: 2183222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
